These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 647189)

  • 41. Additive effects shown by combinations of nitroxyl and electron-affinic hypoxic cell sensitizers.
    Johansen I; Gulbrandsen R; Fielden EM; Sapora O
    Radiat Res; 1977 Jun; 70(3):597-603. PubMed ID: 327503
    [No Abstract]   [Full Text] [Related]  

  • 42. Radiosensitizers of hypoxic cells in solid tumors.
    Fowler JF; Adams GE; Denekamp J
    Cancer Treat Rev; 1976 Dec; 3(4):227-56. PubMed ID: 1016978
    [No Abstract]   [Full Text] [Related]  

  • 43. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations.
    Grdina DJ; Sigdestad CP; Jovonovich JA
    Cancer Clin Trials; 1980; 3(2):149-54. PubMed ID: 7428138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Iodinated nitroimidazoles as radiosensitizers.
    Krause W; Jordan A; Scholz R; Jimenez JL
    Anticancer Res; 2005; 25(3B):2145-51. PubMed ID: 16158957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DNA damage and radiosensitizers: M. luteus sensitive sites for misonidazole-TAN combination.
    Skov KA; Palcic B; Skarsgard LD
    Radiat Res; 1982 Oct; 92(1):113-9. PubMed ID: 7134378
    [No Abstract]   [Full Text] [Related]  

  • 46. The development of some nitroimidazoles as hypoxic cell sensitizers.
    Adams GE; O'Neill P; Ahmed I; Stratford IJ; Fielden EM
    Cancer Clin Trials; 1980; 3(1):37-42. PubMed ID: 7389035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, synthesis, and preliminary biological evaluation of 6-O-glucose-azomycin adducts for diagnosis and therapy of hypoxic tumors.
    Kumar P; Shustov G; Liang H; Khlebnikov V; Zheng W; Yang XH; Cheeseman C; Wiebe LI
    J Med Chem; 2012 Jul; 55(13):6033-46. PubMed ID: 22708968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The radiosensitizing effects of hypoxic cell sensitizer on SCCVII tumors in mice evaluated by highly accurate colony formation assay assisted by microcomputer.
    Ono K; Akuta K; Masunaga S; Kinashi Y; Suzuki M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Dec; 56(14):1066-70. PubMed ID: 9014470
    [No Abstract]   [Full Text] [Related]  

  • 49. Sensitization of Chinese hamster ovary cells to melphalan by etanidazole under intermittent hypoxia.
    Bump EA; Coleman CN; Cerce BA; McGinnis DJ
    Int J Radiat Oncol Biol Phys; 1992; 22(4):731-5. PubMed ID: 1531977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel nitroimidazole alkylsulfonamides as hypoxic cell radiosensitisers.
    Bonnet M; Hong CR; Gu Y; Anderson RF; Wilson WR; Pruijn FB; Wang J; Hicks KO; Hay MP
    Bioorg Med Chem; 2014 Apr; 22(7):2123-32. PubMed ID: 24650701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytotoxicity of radiosensitizers in multicell spheroids: combination treatment with hyperthermia.
    Sutherland R; Macfarlane W
    Br J Cancer Suppl; 1978 Jun; 3():168-72. PubMed ID: 277220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of tumour size on radiosensitization by misonidazole.
    Stanley JA; Peckham MJ; Steel GG
    Br J Cancer Suppl; 1978 Jun; 3():220-4. PubMed ID: 277232
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole.
    Brown DM; Dionet C; Brown JM
    Radiat Res; 1984 Jan; 97(1):162-70. PubMed ID: 6229806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An investigation of the radiosensitizing effects of Ro-07-0582 on hypoxic skin in primates.
    Johnson R; Gomer C; Pearce J
    Int J Radiat Oncol Biol Phys; 1976; 1(7-8):593-9. PubMed ID: 824246
    [No Abstract]   [Full Text] [Related]  

  • 55. The biological properties of reduced nitroheterocyclics and possible underlying biochemical mechanisms.
    Whitmore GF; Varghese AJ
    Biochem Pharmacol; 1986 Jan; 35(1):97-103. PubMed ID: 3510061
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hypoxia: a therapeutic target].
    Fernández-Braña M
    Clin Transl Oncol; 2005 Dec; 7(11):475-6. PubMed ID: 16373057
    [No Abstract]   [Full Text] [Related]  

  • 57. Proceedings: Radiosensitization of hypoxic cells in solid tumours in mice.
    Fowler JF; Adams GE
    Br J Radiol; 1975 Jan; 48(565):77-8. PubMed ID: 1109652
    [No Abstract]   [Full Text] [Related]  

  • 58. Evaluation of novel radiation sensitizers in vitro and in vivo.
    Adams GE; Sheldon PW; Stratford IJ
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):419-21. PubMed ID: 7107361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A phase I clinical study of Nimorazole as a hypoxic radiosensitizer.
    Timothy AR; Overgaard J; Overgaard M
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1765-8. PubMed ID: 6480460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiosensitizing and toxic effects of the 2-nitroimidazole Ro-07-0582 in different phases of the cell cycle of extremely hypoxic human cells in vitro.
    Pettersen EO
    Radiat Res; 1978 Jan; 73(1):180-91. PubMed ID: 622458
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.